Author

Angela Variola

TRANSITION FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB AND VEDOLIZUMAB: ADHERENCE, SATISFACTION AND SAFETY PROFILE IN A COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
TRANSITION FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB AND VEDOLIZUMAB: ADHERENCE, SATISFACTION AND SAFETY PROFILE IN A COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Angela Variola  et al.

DIAGNOSTIC DELAY AND ECONOMIC BURDEN IN IBD: A SINGLE-CENTRE EXPERIENCE IN PATIENTS TREATED WITH BIOLOGICS
DIAGNOSTIC DELAY AND ECONOMIC BURDEN IN IBD: A SINGLE-CENTRE EXPERIENCE IN PATIENTS TREATED WITH BIOLOGICS

Angela Variola  et al.

Item 1 - 2 / 2
1